Oregon, Washington and Idaho are part of a $90 million, 38 state settlement announced Thursday with pharmaceutical giant GlaxoSmithKline. The lawsuit claims the drug company downplayed the cardiovascular risks of the diabetes drug Avandia, which has been linked to an increased risk of heart attacks.
